Related Experiment Video
Updated: Aug 11, 2026

Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier
Published on: November 13, 2013
Adenosine permeation of a dynamic in vitro blood-brain barrier inhibited by dipyridamole
C J Sinclair1, L Krizanac-Bengez, K A Stanness
1Department of Pharmacology and Therapeutics, University of Manitoba, 753 McDermot Avenue, MB R3E 0T6, Winnipeg, Canada.
Abstract:
Adenosine is an inhibitory neuromodulator in the central nervous system and has been reported to have neuroprotective properties. Using a dynamic in vitro blood-brain barrier, we investigated the hypothesis that inhibition of adenosine transporters on the lumenal side of the blood-brain barrier may decrease the loss of adenosine from the brain. Our results indicate that lumenal administration of dipyridamole, a nucleoside transport inhibitor, can inhibit adenosine permeation from the extracapillary space into the lumen.

